Guard Therapeutics
1.60 SEK
+1.59 %
Less than 1K followers
GUARD
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Guard Therapeutics
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -31.8 | -27.1 | -99.9 | -32.7 | -32.8 | -25.8 | ||
| EBIT | -31.8 | -27.1 | -99.9 | -32.7 | -32.8 | -25.8 | -15.9 | -107.2 |
| EBIT-% | ||||||||
| Profit before taxes | -31.7 | -26.0 | -96.1 | -34.2 | -32.2 | -26.1 | -16.3 | -108.9 |
| Net income | -31.7 | -26.0 | -96.1 | -34.2 | -32.2 | -26.1 | -16.3 | -108.9 |